Arnaud Hocquelet1, Charalampos Sotiriadis2, Rafael Duran2, Boris Guiu3, Takamune Yamaguchi4, Nermin Halkic4, Emmanuel Melloul4, Nicolas Demartines4, Alban Denys2. 1. Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, CHUV, Service de radiologie BH07, rue du bugnon 46, 1011, Lausanne, Switzerland. arnaud.hocquelet@chuv.ch. 2. Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, CHUV, Service de radiologie BH07, rue du bugnon 46, 1011, Lausanne, Switzerland. 3. Department of Diagnostic and Interventional Radiology, Montpellier University Hospital, Montpellier, France. 4. Department of Visceral Surgery, Lausanne University Hospital, Lausanne, Switzerland.
Abstract
PURPOSE: To compare estimated future remnant liver (FRL) growth following portal vein embolization or liver venous deprivation (LVD) (combined PVE and right hepatic vein embolization), before surgery for a Klatskin tumor in patients who receive intraoperative biliary drainage or before venous interventional radiology. MATERIAL AND METHOD: Six patients underwent LVD and six underwent PVE alone before hepatectomy for a Klatskin tumor. Before embolization, the FRL ratio, prothrombin time and bilirubin levels were similar in both groups. The FRL was determined before and 3 weeks after embolization by enhanced CT. PVE was performed with n-butyl-2-cyanoacrylate, and the right hepatic vein was embolized with vascular plugs during the same procedure. Biliary drainage was performed percutaneously or by endoscopy. Post-hepatectomy liver function and duration of hospital stay were assessed. RESULTS: There were no adverse events. The median FRL ratio was significantly higher following LVD than after PVE 58% (54-71) and 37% (30-44), respectively, p = 0.017. The FRL volume after embolization was 1.6 times higher after LVD than PVE (p = 0.016). Four and five patients were operated in the LVD and PVE groups, respectively. There was a trend toward a shorter median postoperative hospital stay and 90-day mortality in the LVD versus PVE group: 14 versus 44 days, (p = 0.114) and 0 versus two deaths (p = 0.429), respectively. CONCLUSIONS: LVD associated with biliary drainage is safe and results in a better FRL ratio than biliary drainage associated with PVE alone.
PURPOSE: To compare estimated future remnant liver (FRL) growth following portal vein embolization or liver venous deprivation (LVD) (combined PVE and right hepatic vein embolization), before surgery for a Klatskin tumor in patients who receive intraoperative biliary drainage or before venous interventional radiology. MATERIAL AND METHOD: Six patients underwent LVD and six underwent PVE alone before hepatectomy for a Klatskin tumor. Before embolization, the FRL ratio, prothrombin time and bilirubin levels were similar in both groups. The FRL was determined before and 3 weeks after embolization by enhanced CT. PVE was performed with n-butyl-2-cyanoacrylate, and the right hepatic vein was embolized with vascular plugs during the same procedure. Biliary drainage was performed percutaneously or by endoscopy. Post-hepatectomy liver function and duration of hospital stay were assessed. RESULTS: There were no adverse events. The median FRL ratio was significantly higher following LVD than after PVE 58% (54-71) and 37% (30-44), respectively, p = 0.017. The FRL volume after embolization was 1.6 times higher after LVD than PVE (p = 0.016). Four and five patients were operated in the LVD and PVE groups, respectively. There was a trend toward a shorter median postoperative hospital stay and 90-day mortality in the LVD versus PVE group: 14 versus 44 days, (p = 0.114) and 0 versus two deaths (p = 0.429), respectively. CONCLUSIONS: LVD associated with biliary drainage is safe and results in a better FRL ratio than biliary drainage associated with PVE alone.
Authors: Georg Böning; Uli Fehrenbach; Timo Alexander Auer; Konrad Neumann; Martin Jonczyk; Johann Pratschke; Wenzel Schöning; Moritz Schmelzle; Bernhard Gebauer Journal: Cardiovasc Intervent Radiol Date: 2022-03-21 Impact factor: 2.797
Authors: Emmanuel Deshayes; Lauranne Piron; Antoine Bouvier; Bruno Lapuyade; Emilie Lermite; Laurent Vervueren; Christophe Laurent; Jean-Baptiste Pinaquy; Patrick Chevallier; Anthony Dohan; Agnès Rode; Christian Sengel; Chloé Guillot; François Quenet; Boris Guiu Journal: BMC Cancer Date: 2020-06-19 Impact factor: 4.430
Authors: E Schadde; R M van Dam; R Korenblik; B Olij; L A Aldrighetti; M Abu Hilal; M Ahle; B Arslan; L J van Baardewijk; I Baclija; C Bent; C L Bertrand; B Björnsson; M T de Boer; S W de Boer; R P H Bokkers; I H M Borel Rinkes; S Breitenstein; R C G Bruijnen; P Bruners; M W Büchler; J C Camacho; A Cappelli; U Carling; B K Y Chan; D H Chang; J Choi; J Codina Font; M Crawford; D Croagh; E Cugat; R Davis; D W De Boo; F De Cobelli; J F De Wispelaere; O M van Delden; M Delle; O Detry; R Díaz-Nieto; A Dili; J I Erdmann; O Fisher; C Fondevila; Å Fretland; F Garcia Borobia; A Gelabert; L Gérard; F Giuliante; P D Gobardhan; F Gómez; T Grünberger; D J Grünhagen; J Guitart; J Hagendoorn; J Heil; D Heise; E Herrero; G F Hess; M H Hoffmann; R Iezzi; F Imani; J Nguyen; E Jovine; J C Kalff; G Kazemier; T P Kingham; J Kleeff; O Kollmar; W K G Leclercq; S Lopez Ben; V Lucidi; A MacDonald; D C Madoff; S Manekeller; G Martel; A Mehrabi; H Mehrzad; M R Meijerink; K Menon; P Metrakos; C Meyer; A Moelker; S Modi; N Montanari; J Navines; U P Neumann; P Peddu; J N Primrose; X Qu; D Raptis; F Ratti; F Ridouani; C Rogan; U Ronellenfitsch; S Ryan; C Sallemi; J Sampere Moragues; P Sandström; L Sarriá; A Schnitzbauer; M Serenari; A Serrablo; M L J Smits; E Sparrelid; E Spüntrup; G A Stavrou; R P Sutcliffe; I Tancredi; J C Tasse; V Udupa; D Valenti; Y Fundora; T J Vogl; X Wang; S A White; W A Wohlgemuth; D Yu; I A J Zijlstra; C A Binkert; M H A Bemelmans; C van der Leij Journal: Cardiovasc Intervent Radiol Date: 2022-07-05 Impact factor: 2.797
Authors: Radoslava Stoyanova; Helmut Kopf; Wolfgang Schima; Wolfgang Karl Matzek; Alexander Klaus Journal: Explor Target Antitumor Ther Date: 2022-02-28
Authors: Philip C Müller; Michael Linecker; Elvan O Kirimker; Christian E Oberkofler; Pierre-Alain Clavien; Deniz Balci; Henrik Petrowsky Journal: Langenbecks Arch Surg Date: 2021-03-19 Impact factor: 3.445